RG 13022 is a dimethoxybenzene compound that functions as a tyrosine kinase inhibitor. It selectively inhibits epidermal growth factor receptor (EGFR) activity and is investigated for its effects on cell proliferation and tumor growth in research models.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing RG 13022?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Bz-2'-F-dA
research compound
DMT-2'-F-Bz-dA
research compound
3-Chloro-5-(p-tolyl)-1,2,4-triazine
research compound
(+/-)-11-Nor-9-Tetrahydrocannabinol-[d3]
research compound
(Z)-3-(3,4-dimethoxyphenyl)-2-pyridin-3-ylprop-2-enenitrile
DBGZNJVTHYFQJI-RIYZIHGNSA-N
COC1=C(C=C(C=C1)/C=C(\C#N)/C2=CN=CC=C2)OC
Sourcing RG 13022?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.